July 2022 FDA Recall Drug by Apotex Corp.
D-1285-2022 - Failed dissolution specifications

This Class II drug recall was voluntarily initiated by Apotex Corp. on July 7, 2022 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1285-2022

Reason for Recall
Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.
Initiated
07-07-2022
Reported
07-27-2022
Quantity
2010 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC 60505-2676-3, UPC 3 60505 26763 7), Rx only, Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326

Batch or Lot Expiration Information

Lot# Lots: a) TD9591 Exp. 04/2023; b) TD9592 Exp. 04/2023